MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $183 | -99.9% | 12,627 | 0.0% | 0.03% | -33.3% |
| Q3 2022 | $241,000 | -3.2% | 12,627 | -8.0% | 0.04% | +2.6% |
| Q2 2022 | $249,000 | -28.0% | 13,729 | 0.0% | 0.04% | -17.4% |
| Q1 2022 | $346,000 | -8.7% | 13,729 | 0.0% | 0.05% | -4.2% |
| Q4 2021 | $379,000 | -7.1% | 13,729 | +8.7% | 0.05% | -18.6% |
| Q3 2021 | $408,000 | +5.7% | 12,628 | 0.0% | 0.06% | +9.3% |
| Q2 2021 | $386,000 | -36.5% | 12,628 | -36.8% | 0.05% | -38.6% |
| Q1 2021 | $608,000 | +53.9% | 19,966 | 0.0% | 0.09% | +44.3% |
| Q4 2020 | $395,000 | +110.1% | 19,966 | +38.1% | 0.06% | +74.3% |
| Q3 2020 | $188,000 | +17.5% | 14,454 | +2.8% | 0.04% | +12.9% |
| Q2 2020 | $160,000 | -11.1% | 14,067 | +11.7% | 0.03% | -27.9% |
| Q1 2020 | $180,000 | -47.5% | 12,590 | 0.0% | 0.04% | -27.1% |
| Q4 2019 | $343,000 | -4.7% | 12,590 | 0.0% | 0.06% | -9.2% |
| Q3 2019 | $360,000 | – | 12,590 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |